Gyrodyne Company of America Inc logo

Gyrodyne Company of America Inc(GYRO)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$4.48
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for GYRO

11/13/2026: GYRO (1-star) is currently NOT-A-BUY. Pass it for now.

Gyrodyne Company of America Inc is a micro-cap real estate operating company transitioning through an orderly liquidation and asset monetization plan. Its main strength lies in owning valuable commercial and medical office properties in the New York metropolitan area with minimal debt. The core investment story centers on unlocking net asset value through strategic property sales, such as land parcels in Smithtown. However, investors face execution risks, regulatory delays in zoning approvals, and very thin trading liquidity. The stock suits patient special-situation or value-oriented investors who should closely monitor the successful closing of property sales and cash distribution timelines.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorWeak fitThe company is executing a liquidation and asset realization plan rather than pursuing traditional long-term operational growth.
Momentum investorWeak fitLow trading volume and micro-cap status limit short-term momentum appeal unless triggered by specific liquidation announcements.
Value investorMixed fitTrading at a discount to estimated net asset value, though realizing that value depends on complex real estate transactions.
Dividend investorWeak fitDividends are currently absent or irregular as cash is retained for the winding down of operations.
Low-risk investorWeak fitIlliquidity, micro-cap volatility, and execution risks surrounding property sales create substantial uncertainty.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityHighThin trading liquidity can lead to sharp percentage swings in the share price.
Valuation riskMedium / highRealized asset values may differ significantly from estimated net asset value projections.
Competition riskMediumRegional real estate assets compete with other local commercial and medical space alternatives.
Business qualityMediumThe operating business model is shifting entirely toward a terminal liquidation phase.
Dividend incomeLow / noneIncome investors cannot rely on regular dividend distributions at this stage.
Execution riskHighSuccess depends entirely on closing real estate purchase agreements and securing local approvals.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 9.85M USD
Price to earnings Ratio 40.73
1Y Target Price -
Price to earnings Ratio 40.73
1Y Target Price -
Volume (30-day avg) 2.2K shares
Beta 0.58
52 Weeks Range 3.66 - 9.63
Updated Date 11/15/2026
52 Weeks Range 3.66 - 9.63
Updated Date 11/15/2026
Dividends yield (FY) -
Basic EPS (TTM) 0.11

Sector & Industry Intelligence

Sector

Real Estate

Constructive
Sentiment
Strong Bullish
Momentum
BUY Breadth Improving
BUY participation
64.5%
Active BUY / eligible
20 / 31
30-Day BUY Count Change
+16
Market state
Strong Bullish

More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.

Industry

Real Estate Services

BUY participation
0.0%
Active BUY / eligible
0 / 2
30-Day BUY Count Change
0

Eligible universe: 2 stocks.

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Steep Decline
PRICE PATH

Steep Decline

The stock price has dropped sharply with strong downward pressure.

Moderately Choppy
PRICE STABILITY

Moderately Choppy

The stock has experienced noticeable price swings while retaining some directional structure.

Analysis of Past Performance

Type Stock
Historic Profit -17.81%
Avg. Invested days 29
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 1.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
GYRO receives a 2-star rating, reflecting soft or weak scores across the available pillars. The rating is constrained by weak unit economics, soft analyst coverage, and weak price momentum.

Company Fundamentals

★★★★★
GYRO has moderate overall fundamentals (3 stars), with moderate financial health, soft growth momentum, and solid ownership. In FY2023 versus FY2022, growth and ownership metrics are mixed: slightly negative earnings growth (+0.0%), soft cash generation (FCF margin 0.0%), slightly negative revenue growth (+0.0%).

Financial Health Rating

★★★★★
GYRO's financial health is supported by strong efficiency, including operating-expense and cost-of-revenue discipline (opex 0.0% of revenue). Profitability is weak (1 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
GYRO's growth profile is soft, with the least-weak measure being revenue growth at +0.0% FY2023 versus FY2022. By comparison, while earnings growth (+0.0%, slightly negative) and free-cash-flow growth (-100.0%, negative) hold the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 42.4% and approximately 33.8% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 26.64% supports management-shareholder alignment.

Top 5 Institutional Investors

Towerview LLC 15.37%
Gabelli Funds LLC 9.72%
Gabelli Securities Inc 7.87%
Bulldog Investors, LLC 2.73%
Morgan Stanley - Brokerage Accounts 1.72%

Unit Economics (Per $1K Revenue)

★★★★★
GYRO generates approximately $0 of gross profit, $0 of operating income, and $0 of free cash flow for every $1,000 of revenue. Based on FY2023 results. Weak margins explain the 1-star rating, with weak cash conversion and weak capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: 21.00%

Quantitative Style Profile

★★★★★
GYRO has a relatively low-volatility profile. Weak momentum is the primary drawback, while valuation that is moderately attractive rather than deeply discounted.

Style Classification

Quality Focused

Low VolatilitySmall / Mid Cap Risk

How Company Makes Money

Business areaWhat it includesRetail investor read
Medical Office LeasingRental income generated from healthcare and medical practitioner tenants at properties like Cortlandt Medical Center.Provides steady rental income, though shrinking as liquidation plans proceed.
Industrial and Commercial LeasingLeasing revenue from multi-tenant industrial and office spaces at the Flowerfield facility.Serves as a legacy cash flow source prior to final property sales.
Asset MonetizationProceeds from the sale of land parcels and real estate assets under the corporate liquidation plan.The primary mechanism through which shareholders may ultimately realize returns.

Valuation

Trailing PE 40.73
Forward PE -
Enterprise Value 15.69M
Price to Sales(TTM) 3.6
Enterprise Value 15.69M
Price to Sales(TTM) 3.6
Enterprise Value to Revenue 2.59
Enterprise Value to EBITDA -8.07
Shares Outstanding 2.20M
Shares Floating 743.09K
Shares Outstanding 2.20M
Shares Floating 743.09K
Percent Insiders 26.64
Percent Institutions 42.38

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.